Reklāma
NeuroBo Pharmaceuticals Confirms Marshall Woodworth As New CFO
(RTTNews) - Biotechnology company NeuroBo Pharmaceuticals, Inc. (NRBO) announced Monday the appointment of Marshall Woodworth as Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer, effective March 1, 2024, following his tenure as Acting Chief Financial Officer since October 27, 2023.
Marshall brings in decades of experience as a CFO for a variety of pharmaceutical and medical device companies.
Prior to joining NeuroBo, Woodworth served as the CFO at Nevakar, Inc. from May 2017 through May 2023. Prior to that, he served as the CFO of Braeburn Pharmaceuticals, Inc.
Earlier, Woodworth served as the CFO at Aerocrine AB, and, before that, held the position of CFO at Furiex Pharmaceuticals Inc.
read more
NeuroBo Pharma Gets Approval To Proceed With Phase 2a Trial For DA-1241 To Treat MASH; Stock Up 8%
Biotechnology company NeuroBo Pharmaceuticals, Inc. (NRBO) announced Wednesday the receipt of Safety Review Committee (SRC) approval, recommending that the two-part Phase 2a trial of DA-1241 can continue without modification following a blinded safety review of the first six months of study conduct.
RTTNews
|
533 days ago
Swiss Market Ends Marginally Up
The Switzerland market ended marginally up on Thursday after a choppy ride as stocks swung between gains and losses right through the day's trading session.
RTTNews
|
31 minutes ago
European Stocks Close Weak
European stocks closed lower on Thursday as the mood remained largely cautious with investors closely following geopolitical news, digesting tech giant Nvidia's earnings, and some crucial economic data from the U.S.
RTTNews
|
51 minutes ago
Canadian Stocks Turning In Mixed Performance; TSX Down Marginally
After a positive start and a subsequent drop early on in the session, the Canadian market remains weak around early afternoon on Thursday, weighed down by losses in consumer staples, industrials and communications sectors.
RTTNews
|
1h 24min ago
U.S. Pending Home Sales Fall More Than Expected In July
A report released by the National Association of Realtors on Thursday showed pending home sales in the U.S. fell by more than expected in the month of July. NAR said its pending home sales index decreased by 0.4 percent to 71.7 in July after sliding by 0.8 percent to 72.0 in June. Economists had expected pending home sales to edge down by 0.1 percent.
RTTNews
|
3h 51min ago
Eurozone Economic Confidence Weakens In August
Eurozone economic sentiment softened unexpectedly in August as only industry and retail trade showed improvements, survey results from the European Commission showed Thursday. The economic sentiment indicator slid to 95.2 in August from a revised 95.7 in the previous month. The score was forecast rise to 96.0.
RTTNews
|
4h 1min ago
Walgreen Co. Now Operating As Private Standalone Company Under Sycamore Partners
Independent retail pharmacy Walgreen Co. announced Thursday it is now operating as a private standalone company following the closure of the acquisition of Walgreens Boots Alliance, Inc. (WBA) by New York-based private equity firm Sycamore Partners.
RTTNews
|
4h 13min ago
U.S. Economy Surges More Than Previously Estimated In Q2
The U.S. economy grew by more than previously estimated in the second quarter of 2025, according to revised data released by the Commerce Department on Thursday. The report said real gross domestic product shot up by 3.3 percent in the second quarter compared to the previously reported 3.0 percent surge. Economists had expected the jump in GDP to be upwardly revised to 3.1 percent.
RTTNews
|
4h 24min ago
